<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To observe the clinical therapeutic effect of Shuizhitong capsule (SZT) in treating senile vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) and on changes of related physio-chemical criteria </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Eighty-five patients with VD were randomly divided into the treated group (n = 51) and the control group (n = 34) in the ratio of 3:2, treated with SZT and Piracetam respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Before and after treatment, the Zhang's <z:hpo ids='HP_0000726'>Dementia</z:hpo> Scoring (HDS) and Function of Social Activity Questionnaire (FAQ) scoring, cerebral blood flow and hemorrheologic properties were determined </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: SZT could significantly improve the patients' clinical symptoms, intracranial hemodynamic condition and the hyperviscosity, hypercoagulation and hyperaggregation status, lower the whole blood and plasma specific viscosity, raise the living standard of partial patients, with significant difference between before and after treatment (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: The therapeutic effect of SZT in treating senile VD is definite </plain></SENT>
</text></document>